Literature DB >> 17350944

Particle radiation therapy using proton and heavier ion beams.

Daniela Schulz-Ertner1, Hirohiko Tsujii.   

Abstract

Particle beams like protons and heavier ions offer improved dose distributions compared with photon (also called x-ray) beams and thus enable dose escalation within the tumor while sparing normal tissues. Although protons have a biologic effectiveness comparable to photons, ions, because they are heavier than protons, provide a higher biologic effectiveness. Recent technologic developments in the fields of accelerator engineering, treatment planning, beam delivery, and tumor visualization have stimulated the process of transferring particle radiation therapy (RT) from physics laboratories to the clinic. This review describes the physical, biologic, and technologic aspects of particle beam therapy. Clinical trials investigating proton and carbon ion RT will be summarized and discussed in the context of their relevance to recent concepts of treatment with RT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350944     DOI: 10.1200/JCO.2006.09.7816

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  155 in total

1.  The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.

Authors:  Shohei Komatsu; Takumi Fukumoto; Yusuke Demizu; Daisuke Miyawaki; Kazuki Terashima; Yasue Niwa; Masayuki Mima; Osamu Fujii; Ryohei Sasaki; Isamu Yamada; Yuichi Hori; Yoshio Hishikawa; Mitsuyuki Abe; Yonson Ku; Masao Murakami
Journal:  J Gastroenterol       Date:  2011-04-23       Impact factor: 7.527

2.  When to wait for more evidence? Real options analysis in proton therapy.

Authors:  Janneke P C Grutters; Keith R Abrams; Dirk de Ruysscher; Madelon Pijls-Johannesma; Hans J M Peters; Eric Beutner; Philippe Lambin; Manuela A Joore
Journal:  Oncologist       Date:  2011-12-06

Review 3.  Clinical evidence of particle beam therapy (proton).

Authors:  Takashi Ogino
Journal:  Int J Clin Oncol       Date:  2012-03-17       Impact factor: 3.402

4.  ENLIGHT and other EU-funded projects in hadron therapy.

Authors:  M Dosanjh; B Jones; R Mayer; R Meyer
Journal:  Br J Radiol       Date:  2010-10       Impact factor: 3.039

Review 5.  [Strategies for preoperative downsizing in patients with local nonresectable pancreatic cancer].

Authors:  S E Combs; D Habermehl; J Werner; M W Büchler; J Debus
Journal:  Chirurg       Date:  2011-11       Impact factor: 0.955

6.  Live cell microscopy analysis of radiation-induced DNA double-strand break motion.

Authors:  B Jakob; J Splinter; M Durante; G Taucher-Scholz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-12       Impact factor: 11.205

7.  Surgical organ displacement: what is the best "materials and methods" for proton radiotherapy?

Authors:  Takashi Ogino
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

8.  Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.

Authors:  M Mima; Y Demizu; D Jin; N Hashimoto; M Takagi; K Terashima; O Fujii; Y Niwa; T Akagi; T Daimon; Y Hishikawa; M Abe; M Murakami; R Sasaki; N Fuwa
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

9.  The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.

Authors:  Younghyun Lee; Huizi Keiko Li; Aya Masaoka; Shigeaki Sunada; Hirokazu Hirakawa; Akira Fujimori; Jac A Nickoloff; Ryuichi Okayasu
Journal:  Radiother Oncol       Date:  2016-09-22       Impact factor: 6.280

10.  New paradigms and future challenges in radiation oncology: an update of biological targets and technology.

Authors:  Stanley L Liauw; Philip P Connell; Ralph R Weichselbaum
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.